Invention Grant
- Patent Title: Reconstituted HDL formulation
-
Application No.: US14439094Application Date: 2013-10-31
-
Publication No.: US09925236B2Publication Date: 2018-03-27
- Inventor: Yvonne Vucica , Gary Lee Warren
- Applicant: CSL Limited
- Applicant Address: AU Parkville, Victoria
- Assignee: CSL LIMITED
- Current Assignee: CSL LIMITED
- Current Assignee Address: AU Parkville, Victoria
- Agency: Foley & Larnder LLP
- Priority: EP13153903 20130204; AU2013205684 20130410
- International Application: PCT/AU2013/001260 WO 20131031
- International Announcement: WO2014/066943 WO 20140508
- Main IPC: A61K38/17
- IPC: A61K38/17 ; A61K9/00 ; A61K9/19 ; C07K14/775
Abstract:
The present invention relates to reconstituted high density lipoprotein (rHDL) formulations comprising an apolipoprotein, a lipid and a lyophilization stabilizer. Said formulations have reduced renal toxicity and good long-term stability, especially in lyophilized form.
Public/Granted literature
- US20150306176A1 RECONSTITUTED HDL FORMULATION Public/Granted day:2015-10-29
Information query
IPC分类:
